🇺🇸 NRTIs in United States

19 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 7 reports (36.84%)
  2. Blood Hiv Rna Increased — 2 reports (10.53%)
  3. Encephalitis Viral — 2 reports (10.53%)
  4. Fall — 2 reports (10.53%)
  5. Acute Respiratory Distress Syndrome — 1 report (5.26%)
  6. Colon Neoplasm — 1 report (5.26%)
  7. Death — 1 report (5.26%)
  8. Gait Disturbance — 1 report (5.26%)
  9. Head Injury — 1 report (5.26%)
  10. Nervous System Disorder — 1 report (5.26%)

Source database →

NRTIs in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is NRTIs approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for NRTIs in United States?

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections is the originator. The local marketing authorisation holder may differ — check the official source linked above.